Translating Research Into Practice

Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy

Rita Wickham, PhD, RN, AOCN®

Independent Oncology and Palliative Care Consultant

The author has no conflicts of interest to disclose.

Correspondence to: Rita Wickham, PhD, RN, AOCN®. E-mail: rita_wickham@yahoo.com


J Adv Pract Oncol 2013;4:361–368 | DOI: 10.6004/jadpro.2013.4.5.8 | © 2013 Harborside Press®


  

ABSTRACT

In a recent issue of JAMA, Smith et al. evaluated the use of duloxetine in the treatment of patients with painful chemotherapy-induced peripheral neuropathy (CIPN). Here, JADPRO contributors give an overview of the Smith study and offer a researcher’s perspective on the challenges associated with studying CIPN.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.